News
In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback